Skip to main content
Caplight Logo









BioOrbit

BioOrbit

Private
LondonHealthcare & Life Scienceshttps://bioorbit.space/

Last Round

Seed

Apr 30, 2026

Total Funding Raised

$29.28M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

BioOrbit is a biotechnology company that operates a pharmaceutical factory for the large-scale crystallization of protein drugs in microgravity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Space Technology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

microgravity manufacturingContract Development and Manufacturing OrganisationCDMOin-orbit manufacturingdrug reformulationspace manufacturingin-space manufacturingspace pharmaprotein crystallizationsubcutaneous drug deliverybiologics manufacturingspace biotechIV to SC conversionspace factorymonoclonal antibodiesspace hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioOrbit Comparables

Compare BioOrbit with similar companies based on industry and business-model similarity.

BioOrbit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Space LiinTech
84%
Frontier Space Technologies
81%
SpacePharma
78%

BioOrbit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 30, 2026
SeedApr 30, 2026
GrantFeb 9, 2026

Key People

Founding team and executive leadership

Katie King

CEO And Co-Founder

Founding Team

Jacques Fossey

Chief Technology Officer

Executive Team

BioOrbit Investors

Notable investors and investment history

BioOrbit investors
InvestorRounds
7 Percent VenturesSeed, Pre Seed
BreegaSeed
Phoenix Court GroupSeed
Type One VenturesSeed, Pre Seed
UK Space AgencyGrant
SeedcampSeed, Pre Seed
AuxxoSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Open roles increased to 8, 3.3x the trailing average.

  • Jul 28, 2026

    Grew 33% QoQ from 15 to 20 employees.

BioOrbit Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioOrbit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioOrbit's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range20
Year Founded2023
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?